JP2011522877A5 - - Google Patents

Download PDF

Info

Publication number
JP2011522877A5
JP2011522877A5 JP2011513075A JP2011513075A JP2011522877A5 JP 2011522877 A5 JP2011522877 A5 JP 2011522877A5 JP 2011513075 A JP2011513075 A JP 2011513075A JP 2011513075 A JP2011513075 A JP 2011513075A JP 2011522877 A5 JP2011522877 A5 JP 2011522877A5
Authority
JP
Japan
Prior art keywords
imidazol
methylpyridin
quinoline
fluoro
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011513075A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011522877A (ja
Filing date
Publication date
Priority claimed from US12/155,984 external-priority patent/US20080319012A1/en
Application filed filed Critical
Publication of JP2011522877A publication Critical patent/JP2011522877A/ja
Publication of JP2011522877A5 publication Critical patent/JP2011522877A5/ja
Pending legal-status Critical Current

Links

JP2011513075A 2008-06-12 2009-06-11 Alk5及び/又はalk4抑制体としての2‐ピリジルが置換されたイミダゾール類 Pending JP2011522877A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/155,984 2008-06-12
US12/155,984 US20080319012A1 (en) 2004-04-21 2008-06-12 2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors
PCT/IB2009/006398 WO2009150547A2 (en) 2008-06-12 2009-06-11 2-pyridyl substituted imidazoles as alk4 and/or alk4 inhibitors

Publications (2)

Publication Number Publication Date
JP2011522877A JP2011522877A (ja) 2011-08-04
JP2011522877A5 true JP2011522877A5 (enExample) 2012-06-28

Family

ID=41417193

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011513075A Pending JP2011522877A (ja) 2008-06-12 2009-06-11 Alk5及び/又はalk4抑制体としての2‐ピリジルが置換されたイミダゾール類

Country Status (13)

Country Link
US (2) US20080319012A1 (enExample)
EP (1) EP2303860A4 (enExample)
JP (1) JP2011522877A (enExample)
KR (1) KR101654859B1 (enExample)
CN (1) CN102083811B (enExample)
AU (1) AU2009259021A1 (enExample)
BR (1) BRPI0909899A2 (enExample)
CA (1) CA2727607A1 (enExample)
IL (1) IL209915A (enExample)
MX (1) MX2010013549A (enExample)
RU (1) RU2011100781A (enExample)
WO (1) WO2009150547A2 (enExample)
ZA (1) ZA201100277B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080319012A1 (en) * 2004-04-21 2008-12-25 In2Gen Co., Ltd. 2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors
EP2264017A4 (en) * 2008-04-04 2011-07-27 Takeda Pharmaceutical Heterocyclic derivative and its use
US8513222B2 (en) 2010-06-29 2013-08-20 EWHA University—Industry Collaboration Foundation Methods of treating fibrosis, cancer and vascular injuries
US8080568B1 (en) * 2010-06-29 2011-12-20 Ewha University - Industry Collaboration Foundation 2-pyridyl substituted imidazoles as therapeutic ALK5 and/or ALK4 inhibitors
USRE47141E1 (en) 2010-06-29 2018-11-27 EWHA University—Industry Collaboration Foundation Methods of treating fibrosis, cancer and vascular injuries
USRE47009E1 (en) 2011-02-01 2018-08-28 The Children's Hospital Of Philadelphia HDAC inhibitors and therapeutic methods using the same
CA2841252C (en) * 2011-07-13 2019-02-26 Sk Chemicals Co., Ltd. 2-pyridyl substituted imidazoles as alk5 and/or alk4 inhibitors
EP3894401A2 (en) 2018-12-11 2021-10-20 Theravance Biopharma R&D IP, LLC Naphthyridine and quinoline derivatives useful as alk5 inhibitors
CN114728941A (zh) * 2019-11-22 2022-07-08 施万生物制药研发Ip有限责任公司 作为alk5抑制剂的经取代的1,5-萘啶或喹啉
AU2021205893A1 (en) 2020-01-08 2022-06-23 Synthis Therapeutics, Inc. ALK5 inhibitor conjugates and uses thereof
AR122711A1 (es) * 2020-06-25 2022-09-28 Alchemedicine Inc COMPUESTO HETEROCÍCLICO COMO INHIBIDOR DE CASEÍNA QUINASA 1d Y/O QUINASA 5 TIPO RECEPTOR DE ACTIVINA
WO2022063050A1 (zh) 2020-09-28 2022-03-31 四川科伦博泰生物医药股份有限公司 吡唑类化合物及其制备方法和用途
WO2024258967A1 (en) 2023-06-13 2024-12-19 Synthis Therapeutics, Inc. Anti-cd5 antibodies and their uses

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60001229T2 (de) 1999-04-09 2003-10-30 Smithkline Beecham Corp., Philadelphia Triarylimidazole
AR029803A1 (es) * 2000-02-21 2003-07-16 Smithkline Beecham Plc Imidazoles sustituidos con piridilo y composiciones farmaceuticas que las comprenden
GB0007405D0 (en) 2000-03-27 2000-05-17 Smithkline Beecham Corp Compounds
GB0100762D0 (en) 2001-01-11 2001-02-21 Smithkline Beecham Plc Novel use
CA2448509A1 (en) 2001-05-25 2002-12-05 Mochida Pharmaceutical Co., Ltd. 4-hydroxypiperidine derivatives having analgesic activity
AR039241A1 (es) 2002-04-04 2005-02-16 Biogen Inc Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos
HRP20050252A2 (en) * 2002-09-18 2005-10-31 Pfizer Products Inc. Novel imidazole compounds as transforming growth factor (tfg) inhibitors
WO2005063716A1 (en) * 2003-12-22 2005-07-14 Janssen Pharmaceutica, N.V. Imidazoles and their use cck-1 receptor modulators
US8420685B2 (en) * 2004-04-21 2013-04-16 Sk Chemicals Co., Ltd. 2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors
KR100749566B1 (ko) 2004-04-21 2007-08-16 이화여자대학교 산학협력단 Alk5 및/또는 alk4 억제제로 유효한 2-피리딜이치환된 이미다졸 유도체
US20080319012A1 (en) * 2004-04-21 2008-12-25 In2Gen Co., Ltd. 2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors

Similar Documents

Publication Publication Date Title
JP2011522877A5 (enExample)
RU2011100781A (ru) 2-пиридил-замещенные имидазолы в качестве ингибиторов alk5 и/или alk4
JP2021501220A5 (enExample)
RU2014105169A (ru) 2-пиридилзамещенные имидазолы в качестве ингибиторов alk5 и/или alk4
JP2006506352A5 (enExample)
JP2016164184A5 (enExample)
JP2004525149A5 (enExample)
JP2009518309A5 (enExample)
JP2009536196A5 (enExample)
RU2350616C2 (ru) Производные пиразоло- и имидазопиримидина
JP2017535561A5 (enExample)
JP2005526028A5 (enExample)
CA2564442A1 (en) 2-pyridyl substituted imidazoles as alk5 and/or alk4 inhibitors
JP2004517087A5 (enExample)
JP2014526501A5 (enExample)
JP2009534405A5 (enExample)
TW201006831A (en) Compound and pharmaceutical composition for large conductance calcium-activated K channel opener
RU2010125220A (ru) Ненуклеозидные ингибиторы обратной транскриптазы
JP2008514643A5 (enExample)
JP2008540687A5 (enExample)
JP2013519724A5 (enExample)
JP2002523511A5 (enExample)
RU2007101236A (ru) Новые гидантоиновые производные для лечения обструктивных заболеваний дыхательных путей
JP2013505930A5 (enExample)
JP2018525371A5 (enExample)